{"id":5212,"date":"2022-09-15T14:23:06","date_gmt":"2022-09-15T14:23:06","guid":{"rendered":"https:\/\/phd.hi.is\/?page_id=5212"},"modified":"2022-09-15T15:05:13","modified_gmt":"2022-09-15T15:05:13","slug":"arnar-bragi-ingason","status":"publish","type":"page","link":"https:\/\/phd.hi.is\/en\/arnar-bragi-ingason\/","title":{"rendered":"arnar bragi Ingason"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Arnar Bragi Ingason<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"alt=""\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Greinar sem eru \u00feegar birtar \u00far doktorsverkefninu: https:\/\/pubmed.ncbi.nlm.nih.gov\/34633836\/ <\/a>og https:\/\/pubmed.ncbi.nlm.nih.gov\/35411982\/<\/a><\/p>

\u00cd heildina byggir ritger\u00f0in \u00e1 eftirfarandi 5 greinum:<\/p>

  1. Ingason AB, Hreinsson JP, \u00c1g\u00fastsson AS, Lund SH, Rumba E, P\u00e1lsson DA, Reynisson IE, Gu\u00f0mundsd\u00f3ttir BR, \u00d6nundarson PT, Bj\u00f6rnsson ES. Comparison of the efficacy and safety of direct oral anticoagulants: Nationwide propensity score-weighted study. Under review.

    <\/li>
  2. Ingason AB, Hreinsson JP, \u00c1g\u00fastsson AS, Lund SH, Rumba E, P\u00e1lsson DA, Reynisson IE, Gu\u00f0mundsd\u00f3ttir BR, \u00d6nundarson PT, Bj\u00f6rnsson ES. Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: A nationwide propensity score-weighted study. Ann Intern Med<\/em> 2021;174:1493-502.

    <\/li>
  3. Ingason AB, Hreinsson JP, \u00c1g\u00fastsson AS, Lund SH, Rumba E, P\u00e1lsson DA, Reynisson IE, Gu\u00f0mundsd\u00f3ttir BR, \u00d6nundarson PT, Bj\u00f6rnsson ES. Warfarin is associated with higher rates of upper but not lower gastrointestinal bleeding compared to direct oral anticoagulants: a population-based propensity-weighted cohort study. Clinical Gastroenterology and Hepatology<\/em>. Article in press.

    <\/span><\/li>
  4. Ingason AB, Rumba E, Hreinsson JP, \u00c1g\u00fastsson AS, Lund SH, P\u00e1lsson DA, Reynisson IE, Gu\u00f0mundsd\u00f3ttir BR, \u00d6nundarson PT, Bj\u00f6rnsson ES, Tryggvason G. Warfarin is associated with higher rates of epistaxis compared to direct oral anticoagulants: a nationwide propensity score-weighted study. Journal of Internal Medicine<\/em>. Article in press.

    <\/li>
  5. Ingason AB, Hreinsson JP, Lund SH, \u00c1g\u00fastsson AS, Rumba E, P\u00e1lsson DA, Reynisson IE, Gu\u00f0mundsd\u00f3ttir BR, \u00d6nundarson PT, Bj\u00f6rnsson ES. Comparison of medication adherence between different oral anticoagulants: a population-based propensity-weighted cohort study. Under revie<\/li><\/ol>
    Sj\u00e1 einnig Google Scholar<\/a> me\u00f0 samantekt \u00e1 greinum.<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    Innlend og erlend \u00feing \u00fear sem ni\u00f0urst\u00f6\u00f0ur doktorsranns\u00f3knar voru kynntar<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    Oral Presentations at National Conferences:<\/strong><\/p>

    Ingason AB<\/strong>, Rumba E, Hreinsson JP. \u00c1g\u00fastsson AS, Lund SH, P\u00e1lsson DA, Reynisson IE, Gu\u00f0mundsd\u00f3ttir BR, \u00d6nundarson PT, Tryggvason G, Bj\u00f6rnsson ES. Warfar\u00edn er tengt vi\u00f0 aukna t\u00ed\u00f0ni nefbl\u00e6\u00f0inga samanbori\u00f0 vi\u00f0 beina storkuhemla<\/em> [<\/em>Warfarin is associated with higher rates of epistaxis compared to direct oral anticoagulants]<\/em>. National Surgery and Anesthesiology Conference of Iceland. \u00a02022 April 1st<\/sup>. Reykjavik, Iceland. Presentation received an award for best oral presentation of the conference.<\/strong><\/p>

    Ingason AB<\/strong>, Hreinsson JP, Agustsson AS, Lund SH, Reynisson IE, Gudmundsdottir BR, Onundarson PT, Bjornsson E. Warfarin is associated with higher rates of upper but not lower gastrointestinal bleeding compared to direct oral anticoagulants: A population-based propensity score matched cohort study<\/em>\u201d. Digestive Disease Week. 2020 May 3rd<\/sup>. Virtual conference.<\/p>

    Ingason AB<\/strong>, Hreinsson JP, Lund SH, Bjornsson E. Rivaroxaban is Associated with Higher Rates of Gastrointestinal Bleeding Compared to Other Non-Vitamin K Anticoagulants: A Population-Based Propensity Score-matched Cohort Study<\/em>. Digestive Disease Week. 2019 May 19th<\/sup>. San Diego. CA. \u00a0Presentation received the Young Investigator Award.<\/strong><\/p>


    <\/strong>Posters at National Conferences Outside Iceland:<\/strong><\/p>

    Ingason AB<\/strong>, Hreinsson JP, \u00c1g\u00fastsson AS, Lund SH, Reynisson IE, Gu\u00f0mundsdottir BR, \u00d6nundarson PT, Bj\u00f6rnsson ES. Comparison of Medication Adherence Between Different Oral Anticoagulants: A Propensity Weighted Nationwide Cohort Study. International Society of Thrombosis and Haemostasis Congress. 2020 July 12th<\/sup>. Virtual Conference.<\/p>

    Agustsson AS, Ingason AB<\/strong>, Reynisson IE, Hreinsson JP, Bjornsson ES. Is Oral anticoagulation associated with improved survival in colorectal carcinoma? Digestive Disease Week. 2020 May 2nd<\/sup>. Virtual Conference.<\/p>

    Agustsson AS, Ingason AB<\/strong>, Reynisson IE, Hreinsson JP, Bjornsson ES. Causes of upper gastrointestinal bleeding in oral anticoagulant users compared to non-users. Digestive Disease Week. 2020 May 2nd<\/sup>. Virtual Conference.<\/p>

    Agustsson AS, Ingason AB<\/strong>, Reynisson IE, Hreinsson JP, Bjornsson ES. Causes of lower gastrointestinal bleeding in oral anticoagulant users compared to non-users. Digestive Disease Week. 2020 May 2nd<\/sup>. Virtual Conference.<\/p>

    Ingason AB<\/strong>, Hreinsson JP, Lund SH, Bjornsson ES. Non-vitamin K oral anticoagulants have lower rates of gastrointestinal bleeding compared to warfarin: A population-based propensity score-matched cohort study. Digestive Disease Week. May 20th<\/sup> 2019. San Diego, CA.<\/p>


    Posters at National Conferences in Iceland:<\/strong><\/p>

    Rumba E, Ingason AB<\/strong>, Bj\u00f6rnsson ES, Tryggvason G. Samanbur\u00f0ur \u00e1 me\u00f0fer\u00f0 og alvarleika nefbl\u00e6\u00f0inga tengdri notkun storkuhemla: Landl\u00e6g \u00fe\u00fd\u00f0isranns\u00f3kn. [Comparison of the treatment and severity of epistaxis related to oral anticoagulation use: Nationwide cohort study]<\/em>. National Surgery and Anesthesiology Conference of Iceland. 2022.<\/p>

    Ingason AB<\/strong>, Hreinsson JP, \u00c1g\u00fastsson AS, Lund SH, Rumba E, P\u00e1lsson DA, Reynisson IE, Gu\u00f0mundsd\u00f3ttir BR, \u00d6nundarson PT, Bj\u00f6rnsson ES. Rivaroxaban hefur tengsl vi\u00f0 h\u00e6rri t\u00ed\u00f0ni meltingarvegsbl\u00e6\u00f0inga en a\u00f0rir beinir storkuhemlar [<\/em>Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants<\/em>]<\/em>. National Internal Medicine Conference of Iceland. 2021 November 6th<\/sup>. Received an award for best abstract by a resident.<\/strong><\/p>

    \u00c1g\u00fastsson AS, Ingason AB<\/strong>, P\u00e1lsson D, Rumba E, Reynisson IE, Hreinsson JP, Bj\u00f6rnsson ES. Samanbur\u00f0ur \u00e1 ors\u00f6kum ne\u00f0ri meltingarvegsbl\u00e6\u00f0inga milli einstaklinga \u00e1 bl\u00f3\u00f0\u00feynningu og \u00e1n bl\u00f3\u00f0\u00feynningar um munn [<\/em>Causes of lower gastrointestinal bleeding in oral anticoagulant users compared to non-users<\/em>]<\/em>. National Internal Medicine Conference of Iceland. 2021 November 6th<\/sup>.<\/p>

    \u00c1g\u00fastsson AS, Ingason AB<\/strong>, P\u00e1lsson D, Rumba E, Reynisson IE, Hreinsson JP, Bj\u00f6rnsson ES. Samanbur\u00f0ur \u00e1 ors\u00f6kum efri meltingarvegsbl\u00e6\u00f0inga milli einstaklinga \u00e1 bl\u00f3\u00f0\u00feynningu og \u00e1n bl\u00f3\u00f0\u00feynningar um munn [<\/em>Causes of upper gastrointestinal bleeding in oral anticoagulant users compared to non-users<\/em>]<\/em>. National Internal Medicine Conference of Iceland. 2021 November 6th<\/sup>.<\/p>

    \u00c1g\u00fastsson AS, Ingason AB<\/strong>, P\u00e1lsson D, Rumba E, Reynisson IE, Hreinsson JP, Bj\u00f6rnsson ES. Hefur me\u00f0fer\u00f0 me\u00f0 bl\u00f3\u00f0\u00feynningarlyfjum um munn tengsl vi\u00f0 aukna lifun sj\u00faklinga me\u00f0 ristilkrabbamein? [<\/em>Is Oral anticoagulation associated with improved survival in colorectal carcinoma?<\/em>]<\/em>. National Internal Medicine Conference of Iceland. 2021 November 6th<\/sup>.<\/p>

    Ingason AB<\/strong>, Hreinsson JP, \u00c1g\u00fastsson AS, Lund SH, Rumba E, P\u00e1lsson DA, Reynisson IE, Gu\u00f0mundsd\u00f3ttir BR, \u00d6nundarson PT, Bj\u00f6rnsson ES. Samanbur\u00f0ur \u00e1 me\u00f0fer\u00f0arheldni bl\u00f3\u00f0\u00feynningarlyfja um munn: Landl\u00e6g \u00fe\u00fd\u00f0isranns\u00f3kn [Comparison of adherence between different oral anticoagulants]. <\/em>National Internal Medicine Conference of Iceland. 2021 November 5th<\/sup>.<\/p>

    Rumba E, Ingason AB<\/strong>, Hreinsson JP, Tryggvason G, Bj\u00f6rnsson ES. Samanbur\u00f0ur \u00e1 me\u00f0fer\u00f0 og alvarleika nefbl\u00e6\u00f0inga tengdri notkun storkuhemla: Landl\u00e6g \u00fe\u00fd\u00f0isranns\u00f3kn<\/em> [Comparison of the treatment and severity of epistaxis related to oral anticoagulation use: Nationwide cohort study]<\/em> National Internal Medicine Conference of Iceland. 2021 November 5th<\/sup>.<\/p>

    Ingason AB<\/strong>, Hreinsson JP, \u00c1g\u00fastsson AS, Lund SH, Rumba E, P\u00e1lsson DA, Reynisson IE, Gu\u00f0mundsd\u00f3ttir BR, \u00d6nundarson PT, Bj\u00f6rnsson ES. Rivaroxaban hefur tengsl vi\u00f0 h\u00e6rri t\u00ed\u00f0ni meltingarvegsbl\u00e6\u00f0inga en a\u00f0rir beinir storkuhemlar [<\/em>Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants]<\/em>. V\u00edsindi \u00e1 vord\u00f6gum. 2021 April 28th<\/sup>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

    \n\t\t\t\t
    \n\t\t\t\t\t

    Ver\u00f0laun og vi\u00f0urkenningar<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    RANN\u00cdS styrkur fyrir doktorsverkefni\u00f0. Project title: The efficacy and safety of oral anticoagulants: population-based study
    Grant number: 207113-051<\/p>

    Eftirfarandi ver\u00f0laun fyrir ranns\u00f3knir tengdar doktorsverkefninu:<\/p>